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Cascade oxime formation, cyclization to a nitrone,
and intermolecular dipolar cycloaddition†
Rachel C. Furnival, Rungroj Saruengkhanphasit, Heather E. Holberry,
Jonathan R. Shewring, Hélène D. S. Guerrand, Harry Adams and Iain Coldham*
Simple haloaldehydes, including enolisable aldehydes, were found to be suitable for the formation of
cyclic products by cascade (domino) condensation, cyclisation, dipolar cycloaddition chemistry. This
multi-component reaction approach to heterocyclic compounds was explored by using hydroxylamine, a
selection of aldehydes, and a selection of activated dipolarophiles. Initial condensation gives intermediate
oximes that undergo cyclisation with displacement of halide to give intermediate nitrones; these nitrones
undergo in situ intermolecular dipolar cycloaddition reactions to give isoxazolidines. The cycloadducts
from using dimethyl fumarate were treated with zinc/acetic acid to give lactam products and this provides
an easy way to prepare pyrrolizinones, indolizinones, and pyrrolo[2,1-a]isoquinolinones. The chemistry is
illustrated with a very short synthesis of the pyrrolizidine alkaloid macronecine and a formal synthesis of
petasinecine.
Introduction
Cycloaddition reactions of nitrones have been known for over
50 years.1 The majority of examples involve the condensation
of an aldehyde with an N-alkyl-hydroxylamine or oxidation of
an amine to form the nitrone, followed by cycloaddition with
an alkene dipolarophile.2 An alternative approach makes use
of the condensation of an aldehyde or ketone with hydroxyl-
amine to give an oxime that undergoes subsequent
N-alkylation to give the nitrone. Various N-alkylating agents
can be used and the most common are unsaturated systems
that allow the nitrogen atom of the oxime to undergo conju-
gate addition.3 We have been exploring the N-alkylation of
oximes by intramolecular substitution of an alkyl halide. This
cyclization reaction provides the desired nitrone that under-
goes intramolecular dipolar cycloaddition with an alkene.4,5
So far, we have reported only two examples of inter-
molecular cycloaddition using this strategy and these make
use of a non-enolisable aldehyde as the substrate for reaction
with hydroxylamine.6,7 For example, the aldehyde 1 reacts to
give the intermediate oxime 2 that undergoes cyclization onto
the alkyl chloride to give the nitrone 3 that can be trapped
intermolecularly with dimethyl maleate to give the product 4
as a mixture of diastereoisomers (Scheme 1).6 The enolisable
aldehyde 5 failed to give the desired tricyclic product and led
instead to 3-(pent-4-enyl)pyrrole.4f However, the aldehyde 6
underwent successful condensation with hydroxylamine,
followed by cyclization then intramolecular cycloaddition onto
the internal unactivated alkene, and this was used in a syn-
thesis of myrioxazine A.4c
In this paper, we report successful reactions of aldehydes,
including enolisable aldehydes, with hydroxylamine, followed
by in situ cyclization and intermolecular dipolar cycloaddition.
Scheme 1 Previous studies with related aldehydes.4,6
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The ability to undergo such chemistry is likely due to the use
of reactive, electron-poor alkene dipolarophiles. This chemistry
allows the formation of a greater range of substituted products
without the need to block enolisation.
Results and discussion
Our initial work in this area focused on the simple aldehyde
substrate 7 (Scheme 2). This was prepared by Swern oxidation
of commercially available 5-chloro-1-pentanol.8 Treatment of
the aldehyde 7 with hydroxylamine hydrochloride salt, the
base iPr2NEt, and the dipolarophile dimethyl fumarate gave
the desired bicyclic product 8 in high yield as a single dia-
stereoisomer. The stereochemistry could not be determined at
this stage, although NMR spectroscopic analysis and later
single crystal X-ray analysis of a derivative (see below), revealed
the stereochemistry as shown. The 1H NMR spectroscopic data
for the product 8 match those reported from oxidation of
N-hydroxypiperidine and cycloaddition of the resulting nitrone
with dimethyl fumarate.9
Changing the dipolarophile from dimethyl fumarate to
N-phenylmaleimide gave the desired bicyclic product 9 in high
yield as the major diastereoisomer (dr 4 : 1) (Scheme 3). The
diastereoisomers were separable by column chromatography
and the stereochemistry of the major isomer 9 was determined
by single crystal X-ray analysis. In a similar way, the use of
N-methylmaleimide gave the desired product 10 in high yield
as the major diastereoisomer (dr 4 : 1). The coupling constants
for the methine protons in the cycloadduct 10 matched those
of the cycloadduct 9, indicating the same relative stereo-
chemistry for the major isomer.
Treatment of the cycloadduct 8 with zinc in acetic acid
resulted in reductive cleavage of the N–O bond and subsequent
cyclization of the amine onto one of the ester groups to give
the lactam 11 as a single diastereoisomer (Scheme 4). This
product was crystalline but the needles were too fine for X-ray
analysis. However, conversion of the alcohol 11 to the ester 12
using p-bromobenzoyl chloride gave crystals suitable for X-ray
analysis and allowed the determination of the relative stereo-
chemistry of 12 (and hence of the cycloadduct 8).
Cyclization of the oxime derived from the aldehyde 7 gives
a six-membered ring nitrone. We had previously found that a
six-membered ring nitrone could be prepared and reacted
intramolecularly (by using aldehyde 6, see Scheme 1).4c
However, aldehyde 5 was unsuccessful and resulted in a
pyrrole product. To test the feasibility of conducting the inter-
molecular chemistry with the homologous aldehyde contain-
ing one less methylene unit, we prepared the aldehyde 13. We
were pleased to find that treatment of aldehyde 13 with
hydroxylamine hydrochloride salt, the base iPr2NEt, and the
dipolarophile dimethyl fumarate gave the desired bicyclic
product 14 (as a mixture of diastereoisomers) in high yield
(Scheme 5). The reaction was best conducted by pre-forming
the oxime at 60 °C, then heating to 110 °C in the presence of
the dipolarophile. Product 14 has been reported to be formed
as a mixture of isomers starting from oxidation of
N-hydroxypyrrolidine and cycloaddition of the resulting
1-pyrroline-1-oxide.10 The dipolarophiles N-phenylmaleimide
and N-methylmaleimide gave the desired cycloaddition products
15 and 16 in good yield. The reaction was cleaner on addition
Scheme 2 Aldehyde substrate 7 with dimethyl fumarate.
Scheme 5 Aldehyde substrate 13 with dimethyl fumarate, N-phenyl- or
N-methylmaleimide.
Scheme 3 Aldehyde substrate 7 with N-phenyl- or N-methylmaleimide
(major diastereoisomer of product drawn).
Scheme 4 Preparation of lactam 11 and ester 12.
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
N
ov
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
4/
11
/2
01
6 
16
:0
9:
07
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
of some MgSO4 and n-Bu4NI. The diastereoisomers were separ-
able by column chromatography, although the minor isomer
of the N-phenyl adduct 15 was isolated together with the
adduct of hydroxylamine and N-phenylmaleimide. The stereo-
chemistry of the major isomer of 16 was determined by single
crystal X-ray analysis. This has the same relative stereo-
chemistry as that for the major isomer of the homolog 10. We
assume that the major isomer of 15 also has this relative
stereochemistry.
With the aldehyde substrate 13 we also tested the dipolaro-
phile β-nitrostyrene. This resulted in two products, the minor
one of which was amenable to single crystal X-ray analysis,
revealing the unexpected isomer 17 (Scheme 6). We have not
been able to determine the stereochemistry of the other
isomer 18, but on standing in CDCl3, this converts to a
mixture of 17 and 18. The isomer 17 could arise either from
the isomer 18 (for example by epimerization or via retro-
Mannich reaction) or from a stepwise rather than concerted
cycloaddition process.11
From the results above, it is clear that the aldehyde 13 is
amenable to the desired cascade chemistry involving oxime
formation, cyclization to give a nitrone, followed by inter-
molecular cycloaddition. This requires an activated alkene to
promote cycloaddition, otherwise (as found for compound 5)
the five-membered nitrone is prone to conversion to a pyrrole
ring.
Treatment of the 2 : 1 mixture of cycloadducts 14 with Zn/
AcOH gave the desired lactams 19 and 20 (ratio 2 : 1) that were
separable by careful column chromatography (Scheme 7). The
major product was stereoisomer 19 and the spectroscopic data
matched the reported data.12 The major isomer, lactam 19,
was reduced with LiAlH4 to give the pyrrolizidine alkaloid
(±)-macronecine following a literature procedure (Scheme 7).12
The 1H NMR spectroscopic data matched that reported for the
natural product.13 The chemistry also provides a formal
synthesis of the alkaloid (±)-petasinecine by reduction.12
Therefore the chemistry allows a rapid access to these natural
products in just three steps from 4-chlorobutanal (13).
To complement the examples above, we studied the same
cascade chemistry with the benzaldehyde substrate 21. This
was prepared in two steps from isochroman.6b,14 Condensation
of aldehyde 21 with hydroxylamine at 60 °C followed by
addition of dimethyl fumarate, N-phenylmaleimide or
N-methylmaleimide gave the cycloadducts 22–24 (Scheme 8).
These products were all formed as a single diastereoisomer.
The relative stereochemistry for adducts 22 and 24 was con-
firmed by single crystal X-ray analysis. The preference for the
Scheme 6 Aldehyde substrate 13 with β-nitrostyrene.
Scheme 7 Preparation of the alkaloid macronecine.
Scheme 8 Aldehyde substrate 21 with dimethyl fumarate, N-phenyl- or
N-methylmaleimide.
Scheme 9 Aldehyde substrate 25 with dimethyl fumarate, N-phenyl-
or N-methylmaleimide.
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exo adducts matches that reported from reaction of the iso-
lated nitrone.15
In a similar way, the aldehyde 25 14 was treated with
hydroxylamine at 60 °C followed by addition of dimethyl fuma-
rate, N-phenylmaleimide or N-methylmaleimide to give the
cycloadducts 26–28 (Scheme 9). The relative stereochemistries
of the adducts 27 and 28 were confirmed by single crystal X-ray
analysis.
The products 22 and 26 were treated with zinc in acetic acid
to give the lactams 29 and 30 respectively as single isomers
(Scheme 10).
Conclusions
In conclusion, cascade chemistry involving condensation of
hydroxylamine, cyclization and intermolecular dipolar cyclo-
addition has been shown to be successful with a range of alde-
hydes, including enolisable aldehydes, together with electron-
deficient dipolarophiles to give a variety of bicyclic, tricyclic
and tetracyclic products. The isoxazolidine cycloadducts from
using dimethyl fumarate as the dipolarophile were subjected
to N–O bond cleavage to give, after cyclization,
α-hydroxylactams. The chemistry provides a rapid entry to
nitrogen-containing heterocycles of potential pharmaceutical
interest and application to natural product synthesis, as
demonstrated by a short synthesis of the alkaloid macronecine
and a formal synthesis of petasinecine.
Experimental
5-Chloropentanal 7
DMSO (3.4 mL, 48 mmol) in CH2Cl2 (10 mL) was added to
freshly distilled oxalyl chloride (2.1 mL, 24 mmol) in CH2Cl2
(60 mL) at −78 °C. After 10 min, 5-chloropentan-1-ol (2.4 mL,
20 mmol) in CH2Cl2 (10 mL) was added slowly. After 30 min,
triethylamine (13.9 mL, 100 mmol) was added. The mixture
was allowed to warm to room temperature, then CH2Cl2
(20 mL) and water (20 mL) were added. The aqueous layer was
washed with CH2Cl2 (3 × 50 mL). The combined organic layers
were dried (MgSO4) and evaporated. Purification by column
chromatography, eluting with CH2Cl2, gave aldehyde 7 (2.05 g,
85%) as an oil; Rf 0.8 (CH2Cl2); νmax (film)/cm
−1 2935, 2865,
2730, 1720; 1H NMR (400 MHz, CDCl3) δ = 9.80 (1H, t, J 1.5 Hz,
CHO), 3.60–3.54 (2H, m, CH2), 2.55–2.48 (2H, m, CH2),
1.88–1.77 (4H, m, 2 × CH2);
13C NMR (100 MHz, CDCl3) δ =
201.8, 44.5, 43.0, 31.8, 19.4. Data consistent with the
literature.8
(2R*,3R*,3aR*)-Dimethyl hexahydro-2H-isoxazolo[2,3-a]
pyridine-2,3-dicarboxylate 8
Hydroxylamine hydrochloride (142 mg, 2.04 mmol) and N,N-
diisopropylethylamine (0.74 mL, 4.3 mmol) were added to
aldehyde 7 (204 mg, 1.70 mmol) in PhMe (17 mL) and the
mixture was heated to 110 °C. After 30 min, dimethyl fumarate
(368 mg, 2.55 mmol) was added and heating was continued at
110 °C. After 3.5 h, the mixture was cooled to room tempera-
ture and the solvent was evaporated. Purification by column
chromatography, eluting with CH2Cl2–MeOH (98 : 2), gave the
product 8 (340 mg, 82%) as an oil; Rf 0.36 [CH2Cl2–MeOH
(98 : 2)]; νmax (film)/cm
−1 2950, 2850, 1730; 1H NMR (400 MHz,
CDCl3) δ = 4.84 (1H, d, J 5.5 Hz, CH), 3.81 (3H, s, CH3), 3.79
(3H, s, CH3), 3.60–3.52 (1H, m, CH), 3.42 (1H, dd, J 10, 5.5 Hz,
CH), 2.54 (1H, ddd, J 12, 10, 3 Hz, CH), 2.41–2.32 (1H, m, CH),
2.19–2.10 (1H, m, CH), 1.72–1.65 (3H, m, 2 × CH), 1.50 (1H,
qd, J 13, 4 Hz, CH), 1.31–1.17 (1H, m, 2 × CH); 13C NMR
(100 MHz, CDCl3) δ = 172.0, 171.2, 75.8, 70.5, 56.0, 55.2, 52.7,
52.5, 28.6, 24.3, 23.2; HRMS (ES) Found: MH+, 244.1186.
C11H18NO5 requires MH
+, 244.1185.
(3aR*,3bS*,8aS*)-2-Phenyl-hexahydro-8-oxa-2,7a-diaza-
cyclopenta[a]indene-1,3-dione 9
Hydroxylamine hydrochloride (147 mg, 2.11 mmol) and N,N-
diisopropylethylamine (0.77 mL, 4.4 mmol) were added to
aldehyde 7 (211 mg, 1.76 mmol) in PhMe (17 mL) and the
mixture was heated to 110 °C. After 30 min,
N-phenylmaleimide (457 mg, 2.63 mmol) was added and
heating was continued at 110 °C. After 2 h, the mixture was
cooled to room temperature and the solvent was evaporated.
Purification by column chromatography, eluting with CH2Cl2–
MeOH (99 : 1), gave the product 9 (307 mg, 64%) as a solid and
its diastereomer (83 mg, 17%) as a solid. The product 9
was recrystallized from CH2Cl2–hexanes (1 : 1) as needles;
m.p. 157–159 °C; Rf 0.43 [CH2Cl2–MeOH (98 : 2)]; νmax (film)/
cm−1 2960, 2935, 1710; 1H NMR (400 MHz, CDCl3) δ =
7.52–7.47 (2H, m, 2 × CH), 7.45–7.39 (1H, m, CH), 7.36–7.31
(2H, m, 2 × CH), 4.93 (1H, d, J 7.5 Hz, CH), 3.74–3.68 (1H, m,
CH), 3.56–3.48 (1H, m, CH), 3.39 (1H, dd, J 7.5, 1.5 Hz, CH),
3.08–2.98 (1H, m, CH), 1.89–1.60 (4H, m, 4 × CH), 1.55–1.31
(2H, m, 2 × CH); 13C NMR (100 MHz, CDCl3) δ = 175.2, 174.5,
131.5, 129.2, 128.8, 126.4, 75.1, 63.4, 54.3, 50.3, 25.7, 22.5,
19.3; HRMS (ES) Found: MH+, 273.1250. C15H17N2O3 requires
MH+, 273.1239.
Crystal data deposited at CCDC 1006040.
Unit cell parameters: a 12.9691(19), b 6.6225(11), c 15.583(3),
P21/n.
Scheme 10 Preparation of lactams 29 and 30.
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
N
ov
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
4/
11
/2
01
6 
16
:0
9:
07
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Data for minor stereoisomer: m.p. 135–137 °C; Rf 0.27
[CH2Cl2–MeOH (98 : 2)]; νmax (film)/cm
−1 2960, 2935, 1710; 1H
NMR (400 MHz, CDCl3) δ = 7.52–7.45 (2H, m, 2 × CH),
7.45–7.39 (1H, m, CH), 7.34–7.29 (2H, m, 2 × CH), 4.91 (1H, d,
J 7.5 Hz, CH), 3.64–3.55 (2H, m, 2 × CH), 2.61–2.50 (2H, m, 2 ×
CH), 2.28–2.18 (1H, m, CH), 1.85–1.79 (2H, m, 2 × CH),
1.68–1.53 (1H, m, CH), 1.50–1.37 (1H, m, CH), 1.34–1.19 (1H,
m, CH); 13C NMR (100 MHz, CDCl3) δ = 176.8, 175.6, 131.5,
129.2, 129.0, 126.4, 75.1, 55.1, 50.6, 26.9, 24.4, 23.5, 19.4;
HRMS (ES) Found: MH+, 273.1239. C15H17N2O3 requires MH
+,
273.1239.
(3aR*,3bS*,8aS*)-2-Methyl-hexahydro-8-oxa-2,7a-diaza-
cyclopenta[a]indene-1,3-dione 10
Hydroxylamine hydrochloride (142 mg, 2.04 mmol) and
N,N-diisopropylethylamine (0.74 mL, 4.3 mmol) were added to
aldehyde 7 (204 mg, 1.70 mmol) in PhMe (17 mL) and
the mixture was heated to 110 °C. After 30 min,
N-methylmaleimide (283 mg, 2.55 mmol) was added and
heating was continued at 110 °C. After 3.5 h, the mixture was
cooled to room temperature and the solvent was evaporated.
Purification by column chromatography, eluting with CH2Cl2–
MeOH (98 : 2), gave the product 10 (218 mg, 61%) as a solid
and its diastereomer (54 mg, 15%) as a solid. Data for the
major stereoisomer 10: m.p. 80–83 °C; Rf 0.44 [CH2Cl2–MeOH
(95 : 5)]; νmax (film)/cm
−1 2925, 2860, 1695; 1H NMR (400 MHz,
CDCl3) δ = 4.78 (1H, d, J 7 Hz, CH), 3.60–3.54 (1H, m, CH),
3.51–3.47 (1H, m, CH), 3.22 (1H, dd, J 7, 1.5 Hz, CH), 3.05 (3H,
s, CH3), 3.01–2.90 (1H, m, CH), 1.84–1.74 (2H, m, 2 × CH),
1.67–1.54 (2H, m, 2 × CH), 1.51–1.38 (1H, m, CH), 1.37–1.20
(1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 176.0, 175.4, 75.1,
62.8, 54.4, 50.2, 25.7, 25.0, 22.5, 19.2; HRMS (ES) Found: MH+,
211.1084. C10H15N2O3 requires MH
+, 211.1083.
(1R*,2R*,8aR*)-Methyl 2-hydroxy-3-oxo-octahydroindolizine-
1-carboxylate 11
Zinc powder (186 mg, 2.85 mmol) was added to cycloadduct 8
(165 mg, 0.678 mmol) in AcOH/H2O (14 mL, 5 : 9). The mixture
was heated to 70 °C for 2 h before being cooled to room temp-
erature. The zinc salts were filtered, washed with CH2Cl2 and
the solvent was evaporated. The solute was partitioned
between aqueous ammonia (5 mL) and CH2Cl2 (10 mL), and
the aqueous layer was extracted with CH2Cl2 (3 × 15 mL). The
organic fractions were dried (MgSO4), filtered and evaporated
to give the lactam 11 (102 mg, 70%) as a solid, which was
recrystallized from CH2Cl2–hexanes (1 : 1) as needles;
m.p. 124–127 °C; Rf 0.10 [CH2Cl2–MeOH (99 : 1)]; νmax (film)/
cm−1 3220, 2950, 2920, 2895, 2865, 1740, 1680; 1H NMR
(400 MHz, CDCl3) δ = 4.50 (1H, d, J 7.5 Hz, CH), 4.13 (1H, dt,
J 13, 5 Hz, CH), 3.95–3.87 (1H, m, CH), 3.80 (3H, s, CH3), 2.93
(1H, t, J 7.5 Hz, CH), 2.78 (2H, dt, J 13, 3.5 Hz, 2 × CH),
2.14–2.06 (1H, m, CH), 1.96–1.87 (1H, m, CH), 1.81–1.72 (1H,
m, CH), 1.50 (1H, qt, J 13, 3.5 Hz, CH), 1.40–1.24 (1H, m, CH),
1.11 (1H, qd, J 13, 3.5 Hz, CH); 13C NMR (100 MHz, CDCl3) δ =
170.4, 169.8, 70.2, 56.8, 52.2, 50.4, 40.5, 32.4, 24.1, 23.4; HRMS
(ES) Found: MH+, 214.1070. C10H16NO4 requires MH
+,
214.1079.
(1R*,2R*,8aR*)-Methyl 2-(4-bromobenzoyloxy)-3-oxo-
octahydroindolizine-1-carboxylate 12
p-Bromobenzoyl chloride (875 mg, 5.0 mmol) and DMAP
(60 mg, 0.5 mmol) were added to the lactam 11 (425 mg,
2.0 mmol) in pyridine (2 mL) at room temperature. After 16 h,
the solvent was evaporated. Purification by column chromato-
graphy, eluting with CH2Cl2–MeOH (99 : 1), gave ester 12
(687 mg, 87%) as fine needles; m.p. 90–92 °C; Rf 0.2 [CH2Cl2–
MeOH (99 : 1)]; νmax (film)/cm
−1 2940, 2855, 1735, 1695; 1H
NMR (400 MHz, CDCl3) δ = 7.92 (2H, d, J 8.5 Hz, 2 × CH), 7.60
(2H, d, J 8.5 Hz, 2 × CH), 5.76 (1H, d, J 6.5 Hz, CH), 4.23 (1H,
d, J 14 Hz, CH), 3.75–3.66 (2H, m, 2 × CH), 2.75 (1H, t, J 14 Hz,
CH), 2.04–1.97 (1H, m, CH), 1.92–1.85 (1H, m, CH), 1.83–1.76
(1H, m, CH), 1.55–1.38 (3H, m, 3 × CH); 13C NMR (100 MHz,
CDCl3) δ = 169.0, 166.1, 164.5, 131.8, 131.4, 129.7, 128.6, 70.2,
56.9, 52.4, 48.7, 40.8, 32.4, 24.0, 23.4; HRMS (ES) Found: MH+,
396.0444. C17H19NO5
79Br requires MH+ 396.0447.
Crystal data deposited at CCDC 1022997.
Unit cell parameters: a 11.0353(7), b 21.5973(13), c 15.0726(9),
P21/c.
4-Chlorobutanal 13
DMSO (2.9 mL, 40.6 mmol) in CH2Cl2 (10 mL) was added
dropwise to oxalyl chloride (1.8 mL, 20.3 mmol) in CH2Cl2
(60 mL) at −78 °C. After 10 min, 4-chlorobutanol (1.8 mL,
16.9 mmol) in CH2Cl2 (10 mL) was added dropwise. After
30 min, Et3N (11.8 mL, 84.5 mmol) was added. After 30 min,
the mixture was allowed to warm to room temperature then
water (20 mL) and CH2Cl2 (20 mL) were added. The layers were
separated and the aqueous layer was extracted with CH2Cl2
(3 × 50 mL). The combined organic layers were dried (MgSO4),
filtered and evaporated. Purification by column chromatography,
eluting with CH2Cl2, gave aldehyde 13 (1.09 g, 61%) as an oil;
Rf 0.9 (CH2Cl2);
1H NMR (400 MHz, CDCl3) 9.84 (1H, s, CHO),
3.62 (2H, t, J 6.5 Hz, CH2), 2.70 (2H, t, J 6.5 Hz, CH2), 2.13 (2H,
pent., J 6.5 Hz, CH2). Data consistent with the literature.
16
(2S*,3S*,3aS*)-2,3-Dimethyl hexahydropyrrolo[1,2-b][1,2]
oxazole-2,3-dicarboxylate 14a and (2S*,3S*,3aR*)-2,3-dimethyl
hexahydropyrrolo[1,2-b][1,2]oxazole-2,3-dicarboxylate 14b
To aldehyde 13 (106 mg, 1 mmol) in PhMe (10 mL) was added
hydroxylamine hydrochloride (85 mg, 1.2 mmol) and iPr2NEt
(0.41 mL, 2.4 mmol) and the mixture was warmed to 60 °C.
After 30 min, dimethylfumarate (217 mg, 1.5 mmol) was
added and the mixture was heated under reflux. After 3.5 h,
the mixture was allowed to cool to room temperature and the
solvent was evaporated. Purification by column chromato-
graphy, eluting with CH2Cl2–MeOH (99 : 1) gave cycloadducts
14a and 14b (200 mg, 0.87 mmol, 87%) as an oil, as an in-
separable mixture of diastereoisomers (dr 2 : 1); alternatively,
aldehyde 13 (500 mg, 4.7 mmol) in PhMe (50 mL), hydroxyl-
amine hydrochloride (390 mg, 5.6 mmol), iPr2NEt (2.0 mL,
11 mmol) and dimethylfumarate (1.0 g, 7.0 mmol) gave, after
Organic & Biomolecular Chemistry Paper
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heating for 17 h then purification as above, the cycloadducts
14a and 14b (770 mg, 3.4 mmol, 72%) as an oil (dr 2 : 1); Rf 0.5
[CH2Cl2–MeOH (98 : 2)]; νmax (film)/cm
−1 2955, 1735; 1H NMR
(500 MHz, CDCl3) δ = 4.98 (0.35H, d, J 5.5 Hz, CH), 4.85
(0.65H, d, J 7.5 Hz, CH), 4.13–4.08 (0.35H, dd, J 7.5, 5.0 Hz,
CH), 3.93–3.85 (1H, m, CH), 3.81 (3H, s, 2 × Me), 3.79 (3H, s,
2 × Me), 3.57–3.49 (0.35H, ddd, J 14.0, 8.0, 3.5 Hz, CH), 3.39
(0.65H, dd, J 7.5, 5.0 Hz CH), 3.39–3.43 (0.35H, m, CH),
3.13–3.02 (1.3H, m, 2 × CH), 2.13–1.99 (1.65H, m, 3 × CH),
1.86–1.72 (2H, m, 2 × CH), 1.63–1.53 (0.35H, m, CH); 13C
(125.7 MHz, CDCl3) δ = 171.7, 170.9, 170.5, 169.9, 78.9, 76.0,
69.7, 68.3, 57.4, 56.3, 56.2, 55.1, 52.7, 52.65, 52.6, 52.4, 29.8,
26.6, 24.3, 23.2; HRMS (ES) Found: MH+, 230.1022. C10H16NO5
requires MH+ 230.1028. 1H NMR data consistent with the
literature.9
(1S*,2S*,6R*)-4-Phenyl-7-oxa-4,8-diazatricyclo[6.3.0.01]un-
decane-3,5-dione 15
To aldehyde 13 (106 mg, 1 mmol) in PhMe (10 mL) was added
hydroxylamine hydrochloride (76 mg, 1.1 mmol), iPr2NEt
(0.41 mL, 2.4 mL), dry MgSO4 (∼200 mg) and Bu4NI (37 mg,
0.1 mmol) and the mixture was warmed to 60 °C. After 30 min,
N-phenylmaleimide (260 mg, 1.5 mmol) was added and the
mixture was heated under reflux. After 3.5 h, the mixture was
allowed to cool to room temperature and the solvent was evap-
orated. Purification by column chromatography, eluting with
CH2Cl2–MeOH (99 : 1), gave cycloadduct 15 (168 mg, 65%) as
an oil; Rf 0.4 [CH2Cl2–MeOH (99 : 1)]; νmax (film)/cm
−1 2960,
1710, 1498; 1H NMR (400 MHz, CDCl3) δ = 7.55–7.33 (5H, m,
Ph), 4.97 (1H, d, J 7.5 Hz, CH), 3.90 (1H, t, J 8.0 Hz, CH), 3.73
(1H, d, J 7.5 Hz, CH), 3.66–3.58 (2H, m, 2 × CH), 3.07 (1H, dt,
J 14.5, 8.5 Hz, CH), 2.07–1.98 (1H, m, CH), 1.93–1.73 (2H, m,
2 × CH); 13C NMR (101 MHz, CDCl3) δ = 174.8, 174.4, 131.4,
129.2, 128.9, 126.4, 75.9, 70.8, 55.9, 54.2, 30.0, 24.3; HRMS
(ES) Found: MH+, 259.1074. C14H15N2O3 requires MH
+,
259.1083.
The minor diastereomer was isolated as a mixture with the
adduct formed from conjugate addition of hydroxylamine with
the maleimide.
(1S*,2S*,6R*)-4-Methyl-7-oxa-4,8-diazatricyclo[6.3.0.01]un-
decane-3,5-dione 16a and (1R*,2S*,6R*)-4-methyl-7-oxa-4,8-
diazatricyclo[6.3.0.01]undecane-3,5-dione 16b
To aldehyde 13 (106 mg, 1 mmol) in PhMe (10 mL) was added
hydroxylamine hydrochloride (76 mg, 1.1 mmol), iPr2NEt
(0.41 mL, 2.4 mL), dry MgSO4 (∼200 mg) and Bu4NI (37 mg,
0.1 mmol) and the mixture was warmed to 60 °C. After 30 min,
N-methylmaleimide (260 mg, 1.5 mmol) was added and the
mixture was heated under reflux. After 3.5 h, the mixture was
allowed to cool to room temperature and the solvent was evap-
orated. Purification by column chromatography, eluting with
CH2Cl2–MeOH (99 : 1), gave cycloadduct 16a (96 mg, 49%) as
an oil and the cycloadduct 16b (43 mg, 22%) as an oil, both of
which recrystallised from EtOAc as cubes.
Data for adduct 16a: m.p. 91–93 °C; Rf 0.4 [CH2Cl2–MeOH
(95 : 5)]; νmax (film)/cm
−1 2955, 1705; 1H NMR (400 MHz,
CDCl3) δ = 4.86 (1H, d, J 7.0 Hz, CH), 4.00–3.91 (2H, m, 2 ×
CH), 3.38–3.30 (1H, m, CH), 3.18–3.06 (1H, m, CH), 3.04 (3H,
s, CH3), 2.07–1.94 (2H, m, 2 × CH), 1.90–1.80 (1H, m, CH),
1.75–1.64 (1H, m, CH); 13C NMR (101 MHz, CDCl3) δ = 174.8,
172.0, 77.6, 67.9, 55.8, 53.6, 29.7, 25.0, 24.1; HRMS (ES) Found:
MH+, 197.0922. C9H13N2O3 requires MH
+, 197.0926.
Crystal data deposited at CCDC 1051097.
Unit cell parameters: a 7.9208(3), b 16.5681(9), c 6.7713(3),
Pna21.
Data for adduct 16b: m.p. 88–91 °C; Rf 0.3 [CH2Cl2–MeOH
(95 : 5)]; νmax (film)/cm
−1 2955, 1700; 1H NMR (400 MHz,
CDCl3) δ = 4.83 (1H, d, J 7.0 Hz, CH), 3.77 (1H, t, J 8.5 Hz,
CH), 3.61–3.52 (2H, m, 2 × CH), 3.06 (3H, s, CH3), 3.04–2.96
(1H, m, CH), 2.23–2.12 (2H, m, 2 × CH), 1.88–1.80
(1H, m, CH), 1.75–1.68 (1H, m, CH); 13C NMR (101 MHz,
CDCl3) δ = 174.8, 172.1, 77.6, 67.9, 55.8, 53.6, 25.7, 25.0, 24.1;
HRMS (ES) Found: MH+, 197.0917. C9H13N2O3 requires MH
+,
197.0926.
(2R*,3R*,3aR*)-3-Nitro-2-phenyl-hexahydropyrrolo[1,2-b][1,2]
oxazole 17 and another isomer of 3-nitro-2-phenyl-
hexahydropyrrolo[1,2-b][1,2]oxazole 18
To aldehyde 1 (106 mg, 1 mmol) in PhMe (10 mL) was added
hydroxylamine hydrochloride (76 mg, 1.1 mmol), iPr2NEt
(0.41 mL, 2.4 mL), MgSO4 (∼200 mg) and Bu4NI (37 mg,
0.1 mmol) and the mixture was warmed to 60 °C. After 30 min,
trans-β-nitrostyrene (224 mg, 1.5 mmol) was added and the
mixture was heated under reflux. After 3.5 h, the mixture was
allowed to cool to room temperature and the solvent was evap-
orated. Purification by column chromatography, eluting with
petrol–EtOAc (8 : 2 to 1 : 1), gave cycloadducts 17 (56 mg, 24%)
as a solid and 18 (152 mg, 65%) as an oil.
Data for adduct 17: m.p. 89–92 °C; Rf 0.4 [petrol–EtOAc
(1 : 1)]; νmax (film)/cm
−1 2980, 1550, 1455; 1H NMR (400 MHz,
CDCl3) δ = 7.41–7.34 (5H, m, Ph), 5.50 (1H, d, J 5.5 Hz, CH),
5.24 (1H, dd, J 5.5, 1.5 Hz, CH), 4.51 (1H, broad t, J 7.5 Hz,
CH), 3.50 (1H, dt, J 11.5, 5.5 Hz, CH), 3.21 (1H, dt, J 11.5, 7.5
Hz, CH), 2.35–2.25 (1H, m, CH), 2.08–1.99 (1H, m, CH),
1.94–1.77 (2H, m, 2 × CH); 13C NMR (101 MHz CDCl3) δ =
132.0, 129.3, 128.6, 126.5, 98.4, 80.8, 68.7, 56.4, 29.9, 24.0;
HRMS (ES) Found: MH+, 235.1073. C12H15N2O3 requires MH
+,
235.1083; Anal. Calcd for C12H14N2O3: C, 61.5; H, 6.0; N, 12.0.
Found: C, 61.9; H, 6.0; N, 11.7.
Crystal data deposited at CCDC 1006037.
Unit cell parameters: a 9.0398(3), b 7.2748(3), c 17.0449(6),
P21/c.
Data for adduct 18: Rf 0.6 [petrol–EtOAc (4 : 1)]; νmax (film)/
cm−1 2980, 1545, 1500; 1H NMR (400 MHz, CDCl3) δ =
7.49–7.35 (5H, m, Ph), 5.75 (1H, d, J 6.0 Hz, CH), 5.43 (1H, dd,
J 8.5, 6.0 Hz, CH), 4.29 (1H, br q, J 7.5 Hz, CH), 3.50 (1H,
dt, J 12.5, 6.5 Hz, CH), 3.32 (1H, dt, J 12.5, 7.0 Hz, CH),
2.08–1.97 (4H, m, 4 × CH); 13C NMR (101 MHz CDCl3)
δ = 132.3, 128.9, 128.8, 126.3, 96.4, 79.4, 68.1, 56.7, 26.4, 23.9;
HRMS (ES) Found: MH+, 235.1088. C12H15N2O3 requires MH
+,
235.1083.
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(1S*,2S*,6aR*)-Methyl 2-hydroxy-3-oxo-hexahydro-1H-
pyrrolizine-1-carboxylate 19 and (1S*,2S*,6aS*)-methyl
2-hydroxy-3-oxo-hexahydro-1H-pyrrolizine-1-carboxylate 20
To a 2 : 1 mixture of cycloadducts 14 (215 mg, 0.9 mmol) in
H2O (3.5 mL) and AcOH (2.5 mL) was added zinc (280 mg,
4.3 mmol) and the mixture was heated under reflux. After
22 h, the mixture was cooled to room temperature. The
mixture was diluted with CH2Cl2 (50 mL) and aqueous NH3
(5 mL, 35%), the layers separated and the aqueous layer was
extracted with CH2Cl2 (3 × 50 mL). The combined organic
layers were dried (MgSO4), filtered and concentrated under
reduced pressure. Purification by column chromatography,
eluting with CH2Cl2–
iPrOH (97 : 3), gave the lactams 19 and 20
(combined yield of 142 mg, 79%). The pure lactams were iso-
lated after careful chromatography: 19 (72 mg, 40%), 20
(32 mg, 18%) and both were recrystallized from hot EtOAc as
needles.
Alternatively, a 2 : 1 mixture of cycloadducts 14 (500 mg,
2.2 mmol), H2O (11 mL), AcOH (5.5 mL) and zinc (600 mg,
9.2 mmol) gave, after heating for 22 h then purification as
above, the lactams 19 (129 mg, 30%) and 20 (70 mg, 16%).
Data for lactam 19: m.p. 138–141 °C, lit.12 m.p. for (+)-19:
191–192 °C; Rf 0.6 [CH2Cl2–
iPrOH–NH3 (90 : 9 : 1)];
1H NMR
(400 MHz, CDCl3) δ = 4.63 (1H, dd, J 6.0, 4.0 Hz, CH), 4.42 (1H,
ddd, J 9.0, 8.0, 5.5 Hz, NCH), 3.85 (1H, d, J 4.0 Hz, OH), 3.80
(3H, s, CH3), 3.52 (1H, dt, J 12.0, 8.0 Hz, NCH), 3.22 (1H, ddd,
J 12.0, 8.5, 3.5 Hz, NCH), 2.95 (1H, dd, J 8.0, 6.0 Hz, CH),
2.28–2.13 (3H, m, 3 × CH), 1.44–1.32 (1H, m, CH). Data corres-
pond to the literature.12
Data for lactam 20: m.p. 182–185 °C, lit.12 m.p. for 20 was
not reported; Rf 0.5 [CH2Cl2–
iPrOH–NH3 (90 : 9 : 1)];
1H NMR
(400 MHz, CDCl3) δ = 4.76 (1H, br s, CH), 3.98 (1H, dt, J 8.0,
6.5 Hz, NCH), 3.74 (3H, s, CH3), 3.67 (1H, t, J 6.5 Hz, CH), 3.63
(1H, dt, J 11.5, 7.0 Hz, NCH), 3.10–3.22 (2H, m, NCH and OH),
2.13–1.97 (3H, m, 3 × CH), 1.59–1.47 (1H, m, CH). Data corres-
pond to the literature.12
Macronecine
The lactam 19 (126 mg, 0.63 mmol) in THF (9 mL) was added
to a solution of LiAlH4 (148 mg, 3.91 mmol) in THF (4 mL).
The grey suspension was then heated under reflux. After 17 h,
the mixture was cooled to room temperature and aqueous
NaOH (0.3 mL, 2 M) was added. After 1 h, the suspension was
filtered and was washed with MeOH (60 mL). The filtrate was
concentrated to give a white solid which was purified by
column chromatography on silica with a plug of Celite, eluting
with CH2Cl2–MeOH–NH3 (10 : 5 : 1), to give macronecine
(70 mg, 70%) as an amorphous solid; m.p. 106–108 °C, lit.13g
m.p. 107–108 °C; Rf 0.1 [CH2Cl2–MeOH–NH3 (10 : 5 : 1)];
1H
NMR (400 MHz, CDCl3) δ = 4.50 (1H, t, J 4.0 Hz, CH), 4.34 (2H,
br s, 2 × OH), 3.89–3.82 (2H, m, 2 × CH), 3.56–3.50 (1H, m,
CH), 3.17 (1H, d, J 11.0 Hz, CH), 2.97 (1H, td, J 11.0, 6.5 Hz,
CH), 2.67 (1H, dd, J 11.0, 3.5 Hz, CH), 2.59–2.54 (1H, m, CH),
2.00–1.92 (1H, m, CH), 1.87–1.76 (3H, m, 3 × CH), 1.57–1.50
(1H, m, CH). Data corresponds to the literature.12,13
(1S*,2S*,10bR*)-1,2-Dimethyl 2,5,6,10b-tetrahydro-1H-
isoxazolo[3,2-a]isoquinoline-1,2-dicarboxylate 22
Hydroxylamine hydrochloride (56 mg, 0.81 mmol) and N,N-
diisopropylethylamine (0.28 mL, 1.62 mmol) were added to
aldehyde 21 14 (154 mg, 0.67 mmol) in PhMe (7 mL) and the
mixture was heated to 60 °C. Dimethyl fumarate (117 mg,
0.81 mmol) was added and the mixture was heated under
reflux. After 1 h, the mixture was cooled to room temperature
and the solvent evaporated. Purification by column chromato-
graphy, eluting with CH2Cl2–MeOH (99.7 : 0.3), gave the
product 22 (150 mg, 76%), which was recrystallised from
CH2Cl2–hexanes as needles; m.p. 83–85 °C, lit.
13
m.p. 89–90 °C; Rf 0.5 [CH2Cl2–MeOH (99.5 : 0.5)]; νmax (film)/
cm−1 2955, 1735; 1H NMR (400 MHz, CDCl3) δ = 7.26–7.19 (2H,
m, 2 × CH), 7.16–7.13 (1H, m, CH), 7.07 (1H, d, J 7.0 Hz, CH),
4.95 (1H, d, J 7.5 Hz, CH), 4.89 (1H, d, J 8.5 Hz, CH), 3.88 (3H,
s, CH3), 3.80–3.76 (1H, m, CH), 3.77 (3H, s, CH3), 3.42–3.38
(1H, m, CH), 3.23–3.15 (1H, m, CH), 3.08–3.00 (1H, m, CH),
2.96–2.92 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 171.5,
171.1, 133.2, 132.5, 128.9, 127.6, 127.1, 126.5, 80.9, 67.4, 57.7,
52.8, 52.7, 49.7, 27.9; HRMS (ES) Found MH+, 292.1172,
C15H18NO5 requires MH
+, 292.1185.
Crystal data deposited at CCDC 1006038.
Unit cell parameters: a 9.1248(8), b 32.242(3), c 9.4579(9),
P21/c.
(8aR*,11aS*,11bR*)-10-Phenyl-5,8a,11a,11b-tetrahydropyrrolo
[3′,4′:4,5][1,2]oxazolo[3,2-a]isoquinoline-9,11(6H,10H)-dione 23
Hydroxylamine hydrochloride (124 mg, 1.78 mmol) and N,N-
diisopropylethylamine (0.62 mL, 3.55 mmol) were added to
aldehyde 21 14 (339 mg, 1.48 mmol) in PhMe (15 mL) and the
mixture was heated to 60 °C. After 2 h, N-phenylmaleimide
(308 mg, 1.78 mmol) was added and the mixture was heated
under reflux. After 1 h, the mixture was allowed to cool to
room temperature and the solvent was evaporated. Purification
by column chromatography, eluting with CH2Cl2–MeOH
(99.8 : 0.2), gave cycloadduct 23 (291 mg, 61%) as an amor-
phous solid; m.p. 172–174 °C, lit.15 m.p. 178–179 °C; Rf 0.8
[CH2Cl2–MeOH (99.5 : 0.5)]; νmax (film)/cm
−1 2935, 1715; 1H
NMR (400 MHz, CDCl3) δ = 7.55–7.51 (2H, m, 2 × CH),
7.47–7.44 (2H, m, 2 × CH), 7.41–7.39 (1H, m, CH), 7.35–7.31
(1H, m, CH), 7.28–7.25 (1H, m, CH), 7.16 (1H, d, J 7.5, CH),
4.98–4.95 (2H, m, 2 × CH), 3.93 (1H, dd, 7.5, 2.0 Hz, CH),
3.74–3.66 (1H, m, CH), 3.33–3.21 (2H, m, CH), 2.69–2.62 (1H,
m, CH); 13C NMR (101 MHz, CDCl3) δ = 174.7, 173.8, 133.9,
132.9, 131.4, 129.2, 128.9, 128.8, 127.3 (2 × CH), 127.2, 126.4,
75.7, 65.8, 56.8, 47.8, 22.9; HRMS (ES) Found MH+, 321.1232.
C19H17N2O3 requires MH
+, 321.1239.
(8aR*,11aS*,11bR*)-10-Methyl-5,8a,11a,11b-tetrahydropyrrolo
[3′,4′:4,5][1,2]oxazolo[3,2-a]isoquinoline-9,11(6H,10H)-dione 24
Hydroxylamine hydrochloride (120 mg, 1.73 mmol) and N,N-
diisopropylethylamine (0.60 mL, 3.47 mmol) were added to
aldehyde 21 14 (327 mg, 1.43 mmol) in PhMe (15 mL) and the
mixture was heated to 60 °C. N-Methylmaleimide (192 mg,
Organic & Biomolecular Chemistry Paper
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1.73 mmol) was added and the mixture was heated under
reflux. After 1 h, the mixture was allowed to cool to room temp-
erature and the solvent was evaporated. Purification by column
chromatography, eluting with CH2Cl2–MeOH (99.7 : 0.3), gave
the product 24 (280 mg, 76%), which was recrystallised from
CH2Cl2–hexanes as needles; m.p. 162–164 °C, lit.
11
m.p. 164–166 °C; Rf 0.5 [CH2Cl2–MeOH (99.5 : 0.5)]; νmax
(film)/cm−1 2915, 2825, 1700; 1H NMR (400 MHz, CDCl3) δ =
7.40 (1H, d, J 7.5, CH), 7.31 (1H, t, J 7.5, CH), 7.24 (1H, t, J 7.5,
CH), 7.14 (1H, d, J 7.5, CH), 4.82–4.80 (2H, m, 2 × CH), 3.76
(1H, dd, J 7.5, 2.0 Hz, CH), 3.76–3.66 (1H, m, CH), 3.26–3.20
(2H, m, 2 × CH), 3.12 (3H, s, CH3), 2.64–2.56 (1H, m, CH);
13C
NMR (100 MHz, CDCl3) δ = 175.6, 174.9, 133.8, 132.9, 128.8,
127.3, 127.2, 127.1, 75.7, 65.2, 56.7, 47.7, 25.2, 22.9; HRMS
(ES) Found MH+, 259.1084. C14H15N2O3 requires MH
+,
259.1083.
Crystal data deposited at CCDC 1006039.
Unit cell parameters: a 6.8159(2), b 26.7835(7), c 7.0628(2),
P21/c.
(1S*,2S*,10bR*)-1,2-Dimethyl 8,9-dimethoxy-2,5,6,10b-
tetrahydro-1H-isoxazolo[3,2-a]isoquinoline-1,2-dicarboxylate
26
Hydroxylamine hydrochloride (56 mg, 0.81 mmol) and N,N-
diisopropylethylamine (0.28 mL, 1.62 mmol) were added to
aldehyde 25 14 (154 mg, 0.67 mmol) in PhMe (7 mL) and the
mixture was heated to 60 °C. After 2.5 h, dimethyl fumarate
(126 mg, 0.88 mmol) was added and the mixture was heated
under reflux. After 1 h, the mixture was cooled to room temp-
erature and the solvent was evaporated. Purification by column
chromatography, eluting with CH2Cl2–MeOH (99.5 : 0.5), gave
the cycloadduct 26 (182 mg, 78%) as an amorphous solid;
m.p. 96–99 °C; Rf 0.5 [CH2Cl2–MeOH (98 : 2)]; νmax (film)/cm
−1
2940, 1730, 1610; 1H NMR (400 MHz, CDCl3) δ = 6.61 (1H, s,
CH), 6.58 (1H, s, CH), 4.96 (1H, d, J 7.5 Hz, CH), 4.80 (1H, d,
J 8.5 Hz, CH), 3.87 (6H, s, 2 × CH3), 3.84 (3H, s, CH3), 3.78 (3H,
s, CH3), 3.78–3.74 (1H, m, CH), 3.40–3.37 (1H, m, CH),
3.17–3.13 (1H, m, CH), 3.01–2.94 (1H, m, CH), 2.85–2.80 (1H,
m, CH); 13C NMR (101 MHz, CDCl3) δ = 171.7, 171.2, 148.5,
147.7, 125.5, 124.0, 110.8, 109.7, 80.9, 67.2, 57.6, 55.9
(2 × CH3), 52.8 (2 × CH3), 49.9, 27.7; HRMS (ES) Found: MH
+,
352.1381. C17H22NO7 requires MH
+, 352.1396.
(8aR*,11aS*,11bR*)-2,3-Dimethoxy-10-phenyl-5,8a,11a,11b-
tetrahydropyrrolo[3′,4′:4,5][1,2]oxazolo[3,2-a]isoquinoline-9,11
(6H,10H)-dione 27
Hydroxylamine hydrochloride (150 mg, 2.1 mmol) and N,N-
diisopropylethylamine (0.75 mL, 4.3 mmol) were added to
aldehyde 25 14 (410 mg, 1.8 mmol) in PhMe (18 mL) and the
mixture was heated to 60 °C. After 2.5 h, N-phenylmaleimide
(370 mg, 2.1 mmol) was added and the mixture was heated
under reflux. After 1 h, the mixture was cooled to room temp-
erature and the solvent was evaporated. Purification by column
chromatography, eluting with CH2Cl2–MeOH (99.5 : 0.5), gave
the cycloadduct 27 (500 mg, 74%) as an amorphous solid;
m.p. 185–187 °C (decomposed); Rf 0.7 [CH2Cl2–MeOH (98 : 2)];
νmax (film)/cm
−1 2985, 1710, 1615; 1H NMR (400 MHz, CDCl3)
δ = 7.55–7.51 (2H, m, 2 × CH), 7.47–7.44 (1H, m, CH),
7.40–7.38 (2H, m, 2 × CH), 6.90 (1H, s, CH), 6.63 (1H, s, CH),
5.03 (1H, d, J 7.5 Hz, CH), 4.90 (1H, br, CH), 3.93 (3H, s, CH3),
3.90 (3H, s, CH3), 3.91–3.89 (1H, m, CH), 3.63–3.57 (1H, m,
CH), 3.31–3.25 (1H, m, CH), 3.15–3.08 (1H, m, CH), 2.67–2.60
(1H, m, CH); 13C NMR (101 MHz, CDCl3) δ = 174.9, 173.5,
148.4, 148.3, 131.4, 129.3, 129.0, 126.4, 125.8, 124.3, 111.0,
109.6, 76.0, 65.9, 56.5, 56.2, 56.0, 48.0, 23.4; HRMS (ES) Found:
MH+, 381.1447. C21H21N2O5 requires MH
+, 381.1450; Anal.
Calcd for C21H20N2O5: C, 66.3; H, 5.3; N, 7.4. Found: C, 66.6;
H, 5.1; N, 7.4.
Crystal data deposited at CCDC 1006041.
Unit cell parameters: a 10.6709(10), b 7.6760(7), c 22.1886(18),
P21/c.
(8aR*,11aS*,11bR*)-2,3-Dimethoxy-10-methyl-5,8a,11a,11b-
tetrahydropyrrolo[3′,4′:4,5][1,2]oxazolo[3,2-a]isoquinoline-9,11
(6H,10H)-dione 28
Hydroxylamine hydrochloride (91 mg, 1.3 mmol) and N,N-
diisopropylethylamine (0.45 mL, 2.6 mmol) were added to
aldehyde 25 14 (250 mg, 1.1 mmol) in PhMe (11 mL) and the
mixture was heated to 60 °C. After 2.5 h, N-methylmaleimide
(150 mg, 1.3 mmol) was added and the mixture was heated
under reflux. After 1 h, the mixture was cooled to room temp-
erature and the solvent was evaporated. Purification by column
chromatography, eluting with CH2Cl2–MeOH (99.5 : 0.5), gave
the cycloadduct 28 (280 mg, 81%) as an amorphous solid;
m.p. 154–156 °C (decomposed); Rf 0.7 [CH2Cl2–MeOH (98 : 2)];
νmax (film)/cm
−1 2940, 1700, 1610; 1H NMR (400 MHz, CDCl3)
δ = 6.84 (1H, s, CH), 6.60 (1H, s, CH), 4.86 (1H, d, J 7.5 Hz,
CH), 4.75 (1H, br, CH), 3.93 (3H, s, CH3), 3.89 (3H, s, CH3),
3.73 (1H, dd, J 7.5, 2.5 Hz, CH), 3.60–3.57 (1H, m, CH),
3.24–3.17 (1H, m, CH), 3.12 (3H, s, CH3), 3.13–3.06 (1H, m,
CH), 2.58–2.52 (1H, m, CH); 13C NMR (101 MHz, CDCl3) δ =
175.7, 174.7, 148.3, 148.2, 125.8, 124.3, 111.0, 109.5, 75.8, 65.2,
56.2, 55.9, 55.5, 47.9, 25.2, 23.0; HRMS (ES) Found: MH+,
319.1308. C16H19N2O5 requires MH
+, 319.1294.
Crystal data deposited at CCDC 1006042.
Unit cell parameters: a 9.8243(10), b 8.6128(8), c 17.8328(18),
P21/c.
(1S*,2S*,10bR*)-Methyl 2-hydroxy-3-oxo-1,2,3,4,5,10b-
hexahydropyrrolo[2,1-a]isoquinoline-1-carboxylate 29
Zinc powder (56 mg, 0.85 mmol) was added to cycloadduct 22
(59 mg, 0.20 mmol) in AcOH/H2O (1.5 mL, 1 : 2). The mixture
was heated to 70 °C for 1.5 h before being cooled to room
temperature. The zinc salts were filtered, washed with CH2Cl2
(8 mL) and the solvent was evaporated. The solute was parti-
tioned between aqueous ammonia (4 mL, 18 M) and CH2Cl2
(8 mL), and the aqueous layer was extracted with CH2Cl2 (2 ×
10 mL). The organic fractions were dried (MgSO4), filtered and
evaporated to give the lactam 29 (39 mg, 75%) as needles;
m.p. 181–184 °C, lit.15 m.p. 190–192 °C; Rf 0.4 [CH2Cl2–MeOH
(95 : 5)]; νmax (film)/cm
−1 3250, 2950, 1730, 1680; 1H NMR
(400 MHz, CDCl3) δ = 7.27–7.15 (4H, m, 4 × CH), 5.66 (1H, br,
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
N
ov
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
4/
11
/2
01
6 
16
:0
9:
07
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
OH), 5.48 (1H, d, J 8.0 Hz, CH), 4.61 (1H, d, J 7.5, CH), 4.26
(1H, ddd, J 13.0, 6.0, 3.0, CH), 3.90 (3H, s, CH3), 3.25–3.18 (2H,
m, 2 × CH), 3.00–2.92 (1H, m, CH), 2.87–2.81 (1H, m, CH);
13C NMR (100 MHz, CDCl3) δ = 170.8, 170.1, 135.6, 133.4,
129.2, 127.4, 127.2, 125.2, 71.5, 56.5, 52.6, 52.1, 37.4, 28.5;
HRMS (ES) Found MH+, 262.1075. C14H16NO4 requires MH
+,
262.1079.
(1S*,2S*,10bR*)-Methyl 2-hydroxy-8,9-dimethoxy-3-oxo-
1,2,3,4,5,10b-hexahydropyrrolo[2,1-a]isoquinoline-1-
carboxylate 30
Zinc powder (145 mg, 2.2 mmol) was added to cycloadduct 26
(185 mg, 0.53 mmol) in AcOH/H2O (5 mL, 1 : 2) and the
mixture was heated to 70 °C. After 1.5 h, the zinc salts were fil-
tered, washing the filtrate with CH2Cl2 (15 mL) and the solvent
was evaporated. The solute was partitioned between aqueous
ammonia (5 mL) and CH2Cl2 (10 mL), and the aqueous layer
was extracted with CH2Cl2 (3 × 15 mL). The organic fractions
were dried (MgSO4), filtered and evaporated. The residue was
recrystallized with hot MeOH to give the lactam 30 (81 mg,
47%) as an amorphous solid; m.p. 190–192 °C; Rf 0.29
[CH2Cl2–MeOH (97 : 3)]; νmax (film)/cm
−1 3300, 2990, 1730,
1665; 1H NMR (400 MHz, DMSO-d6) δ = 6.76 (1H, s, CH), 6.66
(1H, s, CH), 6.30 (1H, d, J 6.0 Hz, OH), 5.12 (1H, d, J 8.0 Hz,
CH), 4.26 (1H, dd, J 7.0, 6.0 Hz, CH), 4.06–4.00 (1H, m, CH),
3.75 (3H, s, CH3), 3.72 (3H, s, CH3), 3.66 (3H, s, CH3), 3.17
(1H, dd, J 8.0, 7.0 Hz, CH), 3.07–2.98 (1H, m, CH), 2.70–2.68
(2H, m, 2 × CH); 13C NMR (101 MHz, DMSO-d6) δ = 171.0,
169.9, 148.2, 148.1, 128.2, 126.4, 112.8, 108.7, 71.5, 55.95, 55.9,
55.5, 53.0, 52.4, 36.9, 28.1; HRMS (ES) Found: MH+, 322.1301.
C16H20NO6 requires MH
+, 322.1291; Anal. Calcd for
C16H19NO6: C, 59.8; H, 6.0; N, 4.4. Found: C, 60.1; H, 5.8;
N, 4.3.
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